Laura Holmes Haddad was diagnosed with Stage IV inflammatory breast cancer at 37—the mom of two children ages 1 and 4. A rare and aggressive form of cancer attacking the lymphatic system near the breast, it is a deadly form of the disease—typically far distributed...
Investigators from SWOG Cancer Research Network have confirmed research findings published in the Journal of Clinical Oncology that two biomarkers—a 44-gene DNA Damage Response (DDIR) signature and stromal tumor-infiltrating lymphocytes (sTILs)—can serve as prognostic...
The Metastatic Breast Cancer Alliance (MBCA), the largest coalition of nonprofit breast cancer organizations, pharmaceutical/biotech companies, and patient advocates in America, released MBC Connect 2.0, an interactive web-and-mobile-friendly patient registry...
West Cancer Center breast cancer experts recently discussed promising research being conducted at their research center. Based in Tennessee, West Cancer Center is the region’s comprehensive leader in adult cancer research, delivering a complete continuum of care to...
Noguchi Memorial Institute for Medical Research has participated in some compelling cancer research since its inception in 1979. With an interest in understanding local herbal medicine and how it can augment and contribute to more advanced “Western” medicines, they...
Shanghai Henlius Biotech’s HLX02, a trastuzumab biosimilar, achieved similar overall response rates (ORR) to reference trastuzumab (Herceptin®; Roche) in women with human epidermal growth factor receptor 2-positive (HER2+) recurrent or previously untreated metastatic...
